Insurance Commission Approves New Women-Focused Insurance and HMO Plans Covering Breast Cancer, Maternity, and Reproductive Health

 

The Insurance Commission (IC) has expanded access to women-centered financial protection by approving a new lineup of insurance and Health Maintenance Organization (HMO) products specifically designed to address health conditions that disproportionately affect women. The move reinforces the regulator's push for a more inclusive insurance industry that recognizes the distinct healthcare needs of different population groups.

For 2026, the IC authorized 22 gender-responsive products consisting of 18 life insurance plans, two non-life insurance policies, and two HMO packages. These offerings focus on areas that have traditionally required more specialized coverage, including breast cancer, reproductive healthcare, maternity, and other female-specific medical concerns.

The latest approvals follow the Commission's earlier initiative launched in March 2025, when it encouraged insurance providers and HMOs to develop products that better reflect the realities of women's health. Since then, the regulator has received additional applications from industry players seeking to introduce specialized protection plans.

According to the IC, the growing number of approved products demonstrates stronger participation from insurers in creating solutions that align with gender-responsive objectives. Rather than offering one-size-fits-all coverage, these plans acknowledge that women face health risks that often require dedicated financial protection.

Breast cancer remains a central focus of many of the newly approved products because it continues to be one of the most frequently diagnosed critical illnesses among women. By providing benefits tailored to female-specific conditions, these insurance plans aim to reduce the financial burden associated with diagnosis, treatment, and recovery while giving policyholders greater peace of mind.

Among the newly approved products is AIA Philippines' Breast Cancer Protect Lite, which provides coverage centered on breast cancer. Manulife also received approval for its Female Cancer Insurance (Group) Rider, offering cash assistance to policyholders diagnosed with female-specific cancers.

Sun Life expanded its women-focused portfolio with two approved products. Sun Maiden is structured as a renewable five-year term insurance plan that includes coverage for female critical illnesses. Meanwhile, Sun Maiden Plus builds on the same framework by incorporating maternity benefits, providing broader protection for women during different stages of life.

The healthcare sector also saw new offerings. Insular Health Care obtained approval for She's Well, an HMO diagnostic package developed specifically for women's healthcare needs. The company also introduced Maternity Care, a comprehensive package that covers prenatal consultations, childbirth, postnatal care, and essential healthcare services for newborns.

The Commission emphasized that gender-responsive insurance extends beyond introducing specialized products. Effective coverage should be supported by sex-disaggregated data, allowing insurers to design benefits that accurately reflect health trends, risk profiles, and long-term sustainability. Data-driven product development enables insurers to create plans that remain relevant while strengthening financial protection for policyholders.

As healthcare needs continue to evolve, the Insurance Commission has called on insurers and HMOs to further enhance their product offerings by integrating gender-sensitive features. The regulator believes that expanding specialized insurance solutions will help build a more responsive and inclusive insurance industry capable of meeting the diverse needs of Filipino consumers.